Compounds > staurosporine
Page last updated: 2024-08-23

staurosporine and 1-[3-methoxy-4-[[4-(2-propan-2-ylsulfonylanilino)-1H-pyrrolo[2,3-b]pyridin-6-yl]amino]phenyl]-4-piperidinol

staurosporine has been researched along with 1-[3-methoxy-4-[[4-(2-propan-2-ylsulfonylanilino)-1H-pyrrolo[2,3-b]pyridin-6-yl]amino]phenyl]-4-piperidinol in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brueggemeier, RW; Chettiar, S; Darby, MV; Fisk, HA; Li, C; Li, PK; Mao, L; Sawant, DB; Sugimoto, Y1

Other Studies

1 other study(ies) available for staurosporine and 1-[3-methoxy-4-[[4-(2-propan-2-ylsulfonylanilino)-1H-pyrrolo[2,3-b]pyridin-6-yl]amino]phenyl]-4-piperidinol

ArticleYear
Novel pyrrolopyrimidines as Mps1/TTK kinase inhibitors for breast cancer.
    Bioorganic & medicinal chemistry, 2017, 04-01, Volume: 25, Issue:7

    Topics: Animals; Breast Neoplasms; Cell Cycle Proteins; Female; Humans; Mice; Mice, Nude; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Pyrimidines

2017